Implementation costs of a multi-component program to increase human papillomavirus (HPV) vaccination in a network of pediatric clinics.
Journal
The journal of applied research on children : informing policy for children at risk
ISSN: 2155-5834
Titre abrégé: J Appl Res Child
Pays: United States
ID NLM: 101563140
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
13
8
2020
pubmed:
1
1
2019
medline:
1
1
2019
Statut:
ppublish
Résumé
HPV vaccination is both a clinically and cost-effective way to prevent HPV-related cancers. Increased focus on preventing HPV infection and HPV-related cancers has motivated development of strategies to increase adolescent vaccination rates. This analysis estimates the average cost associated with implementing programs aimed at increasing HPV vaccination from the perspective of the clinic decision makers. As providers and healthcare organizations consider vaccination initiatives, it is important for them to understand the costs associated with implementing these programs. Healthcare provider assessment and feedback, reminders, and education; and parent education/reminder strategies were implemented in a large pediatric clinic network between October 2015 and February 2018 to improve HPV vaccination rates. A micro-costing method was used in 2018 to prospectively estimate program implementation costs with the clinic as the unit of analysis. A sensitivity analysis assessed the effects of variability in levels of participation. Assessment and feedback reports and provider education were implemented among 51 clinics at average per clinic cost of $786 and $368 respectively. Electronic vaccination reminders were delivered to providers and parents at a per clinic cost of $824. The parent education implementation cost was $2,126 per clinic. The four complimentary HPV evidence-based strategies were delivered at a total cost of $157,534 or $4,749 per clinic, including staff training and participant recruitment, reaching 155,000 HPV vaccine eligible adolescents.
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : T32 CA057712
Pays : United States
Références
Sex Transm Dis. 2011 Mar;38(3):197-204
pubmed: 20838362
JAMA Pediatr. 2014 Jan;168(1):76-82
pubmed: 24276343
Br J Cancer. 2008 Dec 2;99(11):1908-11
pubmed: 18985038
Emerg Infect Dis. 2008 Feb;14(2):244-51
pubmed: 18258117
Am J Public Health. 2013 Jan;103(1):164-9
pubmed: 22698055
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917
pubmed: 30138305
Pediatr Infect Dis J. 2013 Jan;32(1):e38-44
pubmed: 22914585
Clin Pediatr (Phila). 2013 Feb;52(2):162-70
pubmed: 23221308
Control Clin Trials. 1990 Apr;11(2):129-46
pubmed: 2161311
Prev Med. 2017 Jun;99:277-281
pubmed: 28322881
Sex Transm Dis. 2012 May;39(5):394-401
pubmed: 22504607
Pediatrics. 2014 Sep;134(3):e666-74
pubmed: 25136036
Vaccine. 2013 Jun 28;31(31):3121-5
pubmed: 23664990
J Sch Nurs. 2011 Dec;27(6):434-46
pubmed: 21750234
Curr Opin Obstet Gynecol. 2012 Oct;24(5):305-10
pubmed: 22781077